MENU
DNTH
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Dianthus Therapeutics (DNTH) Ownership - Who owns Dianthus Therapeutics?
Profile
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
799.61M
P/E Ratio
N/A
Total Cash
360.71M
Projected Growth
N/A
Total Debt
407K
Revenue
4.12M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
12.29
Total Debt/Equity
N/A
Revenue/Share
0.14 USD as % of share price
Fundamentals
DNTH
Capitalization
800M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
361M
Total Cash/Share
12.29
Total Debt
407K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.14%
Revenue
4.12M
ROE
N/A
Book Value
358M
P/B Ratio
2.23
Cash Flow
N/A
Earnings
-1.93
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
36.46
Current Revenue Per Employee
35150.94
Dividends Per Share - Security
N/A
EBITDA
-68.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-15.36
Shares Held By Institutions
967M
Shares Outstanding - Current
29.4M
Total Liabilities
10.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
168.942
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com